For many diseases, well-defined diagnostic and care pathways guide patients, doctors, and caregivers through the patient journey. That is not the case for Alzheimer’s. This panel will discuss what that pathway should look like, starting from the moment a patient prepares to discuss their brain health with their doctor, through subsequent referrals to specialists and treatment options, to exploring potential involvement in clinical trials. Key Question: What needs to happen so that people with cognitive impairment have a smooth path to a reliable diagnosis, appropriate treatment, and access to clinical trials?
